Raspberry leaf tea during pregnancy

How raspberry leaf tea acquired its reputation in pregnancy

Raspberry leaf tea is often suggested as preparation for birth in the third trimester. It has a long history of use, but comparatively little clinical research.

The tea is made from the dried leaves of Rubus idaeus, the red raspberry plant, and is marketed mainly to pregnant people approaching birth. A proposed effect on uterine smooth muscle is often described as “uterotonic”: the idea is that the herb might influence muscle tone or contractions. Whether that translates into easier labor is a separate question. Common preparation descriptions involve steeping dried leaves or a commercial tea bag in boiling water for 5–10 minutes. That describes a drink, not a pregnancy dose shown to be safe or effective.

Midwives have used raspberry leaves within European and North American herbal traditions for centuries. The clinical literature is much smaller than that history might suggest. Two frequently cited studies are a retrospective study from 1999 and a randomized controlled trial from 2001. Both were small. Pure raspberry leaf tea is also easily confused with “pregnancy tea” blends containing nettle, alfalfa, or peppermint, which have different ingredients. 1999 observational study 2001 randomized trial

Supporters commonly associate the tea with four possible benefits:

• “Toning the uterus,” meaning preparing uterine muscle for labor.
• Shortening labor or its second, pushing stage.
• Reducing the need to strengthen contractions medically or use instruments to assist birth.
• Providing micronutrients and compounds with antioxidant activity, including vitamin C and polyphenols, outside pregnancy as well.

These are claims to examine, not four established effects of drinking the tea.

What is in a cup of raspberry leaf tea?

The leaves are the relevant plant material, and composition varies considerably between products.

Leaf preparations should not be treated as equivalent to fruit or stem extracts. In a 2010 laboratory study, commercial raspberry leaf products had different effects on contractions in rat uterine tissue. Some responses were stimulatory and others inhibitory. Neither the name on the package nor a result from one preparation establishes what another product will do. Rat-tissue study

Red raspberry leaves, Rubus idaeus

The dried leaves come from the cultivated red raspberry plant. They differ from the fruit and from other Rubus species. Herbal accounts often refer to “fragarine” in explanations of uterine effects, but the active constituents and their clinical roles remain uncertain. Tannins contribute to the astringent mouthfeel, while polyphenols are central to laboratory research on antioxidant activity. A 2022 study found that stem extracts could show antioxidant or prooxidant activity under different experimental conditions. It does not establish a benefit from drinking leaf tea. 2022 extract study

Amounts such as one tablespoon of dried leaves or one tea bag per 8-fluid-ounce cup, steeped for 5–10 minutes, occur in preparation descriptions. Eight US fluid ounces is about 237 mL. These are not standardized clinical-study doses. The 2001 pregnancy trial used tablets rather than a household tea recipe.

How raspberry leaves might affect uterine muscle

One proposed mechanism involves changes in the contractility of uterine smooth muscle. Fragarine and other leaf constituents have been discussed in this context, but much of the evidence comes from laboratory and animal work, and the responsible compounds are not well established.

The 2010 rat-tissue study found mixed effects depending on the product, pregnancy status, and experimental conditions; it did not support a simple claim that raspberry leaf directly strengthens labor contractions. A 2023 review discussed possible effects on cervical ripening, including potentially unfavorable effects, rather than demonstrating a reliable benefit in pregnant people. The hypotheses remain worth studying, but “raspberry leaf tea” is not a standardized treatment with a predictable effect. A plausible mechanism has not yet translated into consistent clinical results from ordinary tea consumption. 2010 laboratory study 2023 mechanistic review

What the small studies show, and what remains open

The two early studies included 300 participants in total: 108 in the 1999 retrospective study and 192 in the 2001 randomized trial. They assessed different outcomes using different designs. Larger confirmatory trials of birth outcomes were still missing from the evidence reviewed in 2024; that does not mean no subsequent research exists. Newer observational work adds information without resolving causality.

The main questions concern uterine “toning,” labor duration, medical assistance during birth, and antioxidant effects outside pregnancy. Each needs to be considered separately.

Toning the uterus and preparing for contractions: a traditional claim

“Toning the uterus” is a traditional expression, not a clearly defined, validated clinical outcome. The 2010 contractility experiments and the 2023 mechanistic review offer biological questions to investigate. They do not show that the uterus becomes better prepared for birth after drinking tea. Both stimulation and relaxation have appeared in experimental work, depending on conditions. Contractility experiments Mechanistic review

Shorter labor and pushing stage: limited evidence

The early studies suggested possible modest differences in individual stages of labor. In the 2001 trial, participants took two 1.2-g tablets daily from 32 weeks. The first stage was not shortened; the second stage was on average 9.59 minutes shorter in the raspberry-leaf group. This difference did not establish a statistically significant benefit. A 2021 integrative review judged the evidence insufficient for clinical recommendations. Raspberry leaf tea is not an established method of inducing labor in the 2024 AJOG review. It should not be presented as a way to start labor at home. 1999 study 2001 trial 2021 review Labor-induction review

Less medical augmentation or instrument-assisted birth: limited evidence

The early studies also produced encouraging signals for some birth outcomes. In the 2001 trial, forceps delivery occurred in 19.3% of the raspberry-leaf group versus 30.4% of the placebo group, again without a statistically established treatment effect. A 2024 prospective observational study included 91 complete records, 44 exposed to raspberry leaf and 47 unexposed. Use was associated with less medical augmentation and several other favorable outcomes. The authors warned that these results could not be generalized: differences between people who chose the herb and those who did not could help explain the findings. A 2009 clinical review likewise called for larger, better-designed trials. These signals justify research, but do not establish a basis for obstetric treatment decisions. 2009 review 2024 prospective study

Antioxidant benefits outside pregnancy: laboratory evidence

Raspberry leaf and stem extracts contain polyphenols and tannins with measurable antioxidant activity in laboratory assays. The 2022 study also found prooxidant activity in stem extracts under some conditions. Such chemistry cannot be converted directly into a claim that drinking tea improves health. The cited study did not test a clinically meaningful antioxidant outcome in people drinking usual amounts of leaf tea. Extract analysis

How raspberry leaf tea is prepared

Traditional herbal and midwifery descriptions generally involve a simple infusion.

Ingredients

• Dried red raspberry leaves, Rubus idaeus.
• Hot water.

Preparation

During pregnancy, discuss the specific product and intended use with the maternity clinician or midwife before using it. Products vary in composition, and the quantity of leaf and extraction conditions can change what enters the cup. That does not establish a reliable relationship between steeping time and uterine effects, or a recipe that is safe for every pregnancy.

Common blends combine raspberry leaf with nettle, alfalfa, or peppermint. A blend needs to be considered by its complete ingredient list, rather than as raspberry leaf alone.

Longer steeping or a more concentrated infusion should not be assumed to produce a predictable or more useful effect on contractions. Laboratory studies found different responses between preparations, including inhibitory responses. Timing, amount, and whether to use the product at all are questions for the maternity team. A recipe cannot make those decisions.

Risks worth considering

The safety evidence is limited, especially for different doses and stages of pregnancy. Laboratory effects on uterine tissue raise reasonable questions, but they do not establish that ordinary tea causes early labor or prove a specific first- and second-trimester contraindication. The 2009 and 2021 reviews support caution because important information is missing, not because harm at a defined stage has been demonstrated. Discuss use with the maternity team rather than starting it independently. 2009 safety review 2021 integrative review

The UK Committee on Toxicity’s 2024 assessment judged the overall pregnancy risk to be low, with substantial uncertainty. It could not establish a health-based intake limit. That assessment is neither proof of safety for every product nor evidence that early exposure necessarily causes harm. Committee on Toxicity assessment

Specific interaction data are sparse. A 2020 review discusses the wider difficulties of evaluating supplements during pregnancy. Absence of reported interactions does not establish safety. Supplement review A case report described hypoglycemia and reduced insulin requirements in a pregnant patient with gestational diabetes after raspberry leaf tea. A single case cannot determine frequency or prove a general effect, but is relevant when discussing use with a diabetes team.

Product differences complicate interpretation. A 1999 US nurse-midwife survey documented varied use of several herbs and gaps in written protocols; it does not demonstrate that raspberry leaf was universally recommended cautiously or under standardized conditions. The 2010 rat-tissue study likewise showed variable biological responses. “Natural” does not imply a known dose-response relationship. Midwife survey Preparation study

Tell the maternity team about herbal products before investigations, including the brand, ingredients, and amount. The cited evidence does not establish direct interference with prenatal laboratory assays or a routine need for liver tests specifically because someone drinks raspberry leaf tea. A biological change in blood glucose is also different from interference with the test itself.

The practical points to discuss are:

• Use in the first or second trimester, when reliable stage-specific safety data are particularly limited. This is a reason for advice, not proof that an inadvertent cup has harmed the pregnancy.
• Use at any stage without a discussion of the individual pregnancy and product. Traditional timing is not a validated obstetric recommendation.
• Contractions or possible labor without an agreed maternity plan. Raspberry leaf is not an established induction method. Induction review
• Differences between commercial preparations, whose biological effects cannot be assumed equivalent. Laboratory comparison
• Diabetes treatment, other medicines, or planned tests: disclose use so the team can decide whether any extra monitoring is relevant, rather than assuming a known assay-interference effect.

If any of these applies, the next step is a conversation with the clinician or midwife who knows the pregnancy.

Blood tests during pregnancy

How someone feels cannot establish the effect of a herbal tea. Prenatal monitoring follows the pregnancy’s needs, and results should be discussed with the maternity team. Raspberry leaf use does not create a separate routine testing package.

• Ferritin: Iron deficiency is an important pregnancy concern. A blood count and, when indicated, ferritin help assess it. A baseline ferritin test is not automatically necessary just because someone drinks the tea.
• Vitamin D: Supplementation advice and a blood-test indication are different questions. Routine vitamin D testing is not universally part of prenatal care; use local guidance and individual risk.
• Glucose and HbA1c: Gestational-diabetes screening follows the appropriate pregnancy protocol. HbA1c is not interchangeable with a glucose-tolerance test. The case report described above means an effect on glucose should not simply be dismissed, particularly with insulin treatment.
• Outside pregnancy: Ferritin, vitamin D, and hs-CRP are not a validated panel for measuring antioxidant benefits from raspberry leaves. Testing should address an independent clinical question.

NICE antenatal-care guidance and diabetes-in-pregnancy guidance distinguish routine assessment from tests used for particular risks. Local care pathways may differ.

Prenatal follow-up belongs within maternity care. Decisions rely on clinical findings, not on whether tea has been consumed.

Who might consider raspberry leaf tea?

People interested in the tea most often discuss it in the third trimester while receiving maternity care. It remains a traditional preparation rather than an established treatment. A 2022 Australian survey of complementary-product users described use during pregnancy and breastfeeding; it did not show that all use was contrary to clinical advice. A separate 2022 survey found raspberry-leaf use among 38% of 121 respondents. Prevalence tells us about choices, not effectiveness. Complementary-product survey Raspberry-leaf survey

People in the first or second trimester should seek advice rather than begin independently. Anyone hoping to induce labor should work with the maternity team: established induction methods exist, and raspberry leaf tea is not a substitute. Nor does it replace assessment of a suspected nutrient deficiency. Induction review

Alternatives with more research behind them

Start with the actual goal. Labor induction, nutrient intake, and interest in antioxidants involve different decisions and different evidence.

Medically appropriate labor induction: A 2024 AJOG review assessed established induction methods. A 2023 meta-analysis compared elective induction at 39 weeks with expectant management. The latter found benefits for some outcomes alongside potential risks in some groups; it is not a recommendation that everyone should be induced at 39 weeks. The maternity team can discuss the relevant options and tradeoffs. 39-week induction analysis Induction-method review

Prenatal nutrition and care: Recommended prenatal care and supplements tailored to local guidance and individual needs, including folic acid and sometimes iron, vitamin D, or omega-3, have clearer roles than treating tea as birth preparation. These products are not one universal package. A 2018 Cochrane review of omega-3 during pregnancy included a much larger trial base than exists for raspberry leaf, finding fewer preterm births but probably more pregnancies extending beyond 42 weeks. Cochrane review

Antioxidants: A varied diet can provide berries, vegetables, and other sources of nutrients, but the cited 2024 fertility review did not test a berry-and-leafy-vegetable eating pattern. It analyzed antioxidant supplements in women with ovarian aging, with favorable findings particularly for coenzyme Q10 in some treatment settings. Those results do not establish benefits from raspberry leaf tea or a general antioxidant regimen during pregnancy. Fertility meta-analysis

Which baseline findings matter?

During pregnancy, maternity assessment supplies the relevant baseline information. Outside pregnancy, ferritin or vitamin D may be useful for a specific suspected deficiency, not automatically because someone wants to try a tea.

Questions about nutrients and inflammation need their own clinical context. hs-CRP does not measure an overall “antioxidant status,” and routine before-and-after panels cannot isolate this drink’s effect. A 2025 crossover trial in 22 healthy adults did find lower early glucose and insulin responses when raspberry leaf tea accompanied sucrose, but not glucose. That preliminary metabolic finding concerns a specific experimental setting, not pregnancy safety, long-term HbA1c improvement, or a reason to self-manage gestational diabetes. 2025 randomized trial

If the interest in raspberry leaf comes from pregnancy concerns or unexplained gynecologic symptoms, discuss those concerns directly with the appropriate clinician. That makes it easier to consider whether the product fits the individual’s situation at all.

Putting raspberry leaf tea in perspective

Raspberry leaf tea has cultural and personal value for some people preparing for birth. Clinical evidence is a different question, and the decision to use it belongs in a discussion with the maternity team.

The 1999 observational study, 2001 trial, and 2021 integrative review leave open the possibility of modest effects on some labor outcomes. They do not establish a reliable treatment effect or an optimal dose. Experimental uterine effects justify further research and cautious advice, but should not be converted into certainty about either benefit in late pregnancy or harm in early pregnancy. Product, timing, amount, and the individual’s circumstances all matter. 1999 study 2001 trial 2021 review

Frequently asked questions

Is raspberry leaf tea’s effect established?

Using it to induce labor goes beyond the evidence. The small 1999 observational study and 2001 trial suggested possible modest differences in labor stages, but the findings were not a statistically established treatment benefit. The 2021 integrative review found insufficient evidence for clinical recommendations. The early results remain a reason to study the question, not an established induction method. 1999 study

When can you start drinking it during pregnancy?

Discuss timing with the maternity team. Traditional advice often mentions the third trimester, commonly weeks 32–36; the 2001 trial began tablets at 32 weeks. Neither establishes an optimal starting week for tea. Get individual advice before beginning.

What does raspberry leaf tea do to the uterus?

It may influence smooth-muscle activity, but the direction is not reliably predictable. Rat-tissue studies found both stimulation and inhibition under different conditions. Biological activity does not establish easier labor in humans. Rat-tissue study Mechanistic review

Is there a safe daily amount during pregnancy?

No universally safe daily amount has been established. A studied tablet dose is not interchangeable with cups of tea, and steeping longer does not produce a known increase in uterotonic potency. Discuss the product, dose, and stage of pregnancy with the maternity team.

Who should avoid raspberry leaf tea?

People who are pregnant should avoid starting it without discussing their circumstances, especially earlier in pregnancy or if complications or interacting medicines are a concern. This advice reflects uncertainty; it does not mean a proven stage-specific hazard has been established for every tea preparation.

What side effects can occur?

Digestive symptoms have been reported, and a case report raises a possible glucose-lowering interaction during insulin-treated gestational diabetes. Product composition and dose may matter. Laboratory uterine effects remain a concern to investigate, but are not proof that ordinary tea causes early labor. Interaction data are limited. Laboratory preparation study

Can raspberry leaf tea make labor start early?

There is no reliable clinical evidence that ordinary consumption consistently brings labor forward. Experimental effects do not establish either effective induction or a proven early-labor risk at a defined dose. Because pregnancy safety data remain incomplete, use should be discussed with the maternity team. The tea is not an established induction method. Induction review

Which biomarkers should I check if I drink it?

Continue the prenatal assessments advised by the maternity team. A blood count, ferritin, vitamin D, or glucose testing may be relevant for separate reasons, but not as a universal raspberry-leaf panel. HbA1c does not replace appropriate gestational-diabetes testing. Outside pregnancy, ferritin, vitamin D, and hs-CRP are not validated measures of this tea’s benefit. If you use insulin, tell the diabetes team about herbal products rather than adjusting treatment yourself.

Sources

• Parsons M, Simpson M, Ponton T (1999). Raspberry leaf and its effect on labour: safety and efficacy. Australian College of Midwives Incorporated journal, 12(3), 20-5. https://doi.org/10.1016/s1031-170x(99)80008-7

• Simpson M, Parsons M, Greenwood J, Wade K (2001). Raspberry leaf in pregnancy: its safety and efficacy in labor. Journal of midwifery & women’s health, 46(2), 51-9. https://doi.org/10.1016/s1526-9523(01)00095-2

• Zheng J, Pistilli MJ, Holloway AC, Crankshaw DJ (2010). The effects of commercial preparations of red raspberry leaf on the contractility of the rat’s uterus in vitro. Reproductive sciences (Thousand Oaks, Calif.), 17(5), 494-501. https://doi.org/10.1177/1933719109359703

• Garjonyte R, Budiene J, Labanauskas L, Judzentiene A (2022). In Vitro Antioxidant and Prooxidant Activities of Red Raspberry (Rubus idaeus L.) Stem Extracts. Molecules (Basel, Switzerland), 27(13). https://doi.org/10.3390/molecules27134073

• Socha MW, Flis W, Wartęga M, Szambelan M, Pietrus M, Kazdepka-Ziemińska A (2023). Raspberry Leaves and Extracts-Molecular Mechanism of Action and Its Effectiveness on Human Cervical Ripening and the Induction of Labor. Nutrients, 15(14). https://doi.org/10.3390/nu15143206

• Bowman R, Taylor J, Muggleton S, Davis D (2021). Biophysical effects, safety and efficacy of raspberry leaf use in pregnancy: a systematic integrative review. BMC complementary medicine and therapies, 21(1), 56. https://doi.org/10.1186/s12906-021-03230-4

• Sanchez-Ramos L, Levine LD, Sciscione AC, Mozurkewich EL, Ramsey PS, Adair CD, Kaunitz AM, McKinney JA (2024). Methods for the induction of labor: efficacy and safety. American journal of obstetrics and gynecology, 230(3S), S669-S695. https://doi.org/10.1016/j.ajog.2023.02.009

• Bowman RL, Taylor J, Davis DL (2024). Raspberry leaf (Rubus idaeus) use in pregnancy: a prospective observational study. BMC complementary medicine and therapies, 24(1), 169. https://doi.org/10.1186/s12906-024-04465-7

• Holst L, Haavik S, Nordeng H (2009). Raspberry leaf–should it be recommended to pregnant women?. Complementary therapies in clinical practice, 15(4), 204-8. https://doi.org/10.1016/j.ctcp.2009.05.003

• Brown B, Wright C (2020). Safety and efficacy of supplements in pregnancy. Nutrition reviews, 78(10), 813-826. https://doi.org/10.1093/nutrit/nuz101

• McFarlin BL, Gibson MH, O’Rear J, Harman P (1999). A national survey of herbal preparation use by nurse-midwives for labor stimulation. Review of the literature and recommendations for practice. Journal of nurse-midwifery, 44(3), 205-16. https://doi.org/10.1016/s0091-2182(99)00037-3

• Farnaghi S, Braniff K (2022). Survey of Raspberry Leaf Tea in pregnancy. The Australian & New Zealand journal of obstetrics & gynaecology, 62(4), 506-510. https://doi.org/10.1111/ajo.13496

• Barnes LAJ, Rolfe MI, Barclay L, McCaffery K, Aslani P (2022). Demographics, health literacy and health locus of control beliefs of Australian women who take complementary medicine products during pregnancy and breastfeeding: A cross-sectional, online, national survey. Health expectations : an international journal of public participation in health care and health policy, 25(2), 667-683. https://doi.org/10.1111/hex.13414

• Hong J, Atkinson J, Roddy Mitchell A, Tong S, Walker SP, Middleton A, Lindquist A, Hastie R (2023). Comparison of Maternal Labor-Related Complications and Neonatal Outcomes Following Elective Induction of Labor at 39 Weeks of Gestation vs Expectant Management: A Systematic Review and Meta-analysis. JAMA network open, 6(5), e2313162. https://doi.org/10.1001/jamanetworkopen.2023.13162

• Middleton P, Gomersall JC, Gould JF, Shepherd E, Olsen SF, Makrides M (2018). Omega-3 fatty acid addition during pregnancy. The Cochrane database of systematic reviews, 11(11), CD003402. https://doi.org/10.1002/14651858.CD003402.pub3

• Shang Y, Song N, He R, Wu M (2024). Antioxidants and Fertility in Women with Ovarian Aging: A Systematic Review and Meta-Analysis. Advances in nutrition (Bethesda, Md.), 15(8), 100273. https://doi.org/10.1016/j.advnut.2024.100273